Multiple Sclerosis Trial, Recruiting NCT07236684 Sponsor: Artvin Coruh University Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT07236684
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with Multiple Sclerosis (MS) according to a specific set of medical guidelines called the 2017 revised McDonald criteria
  • People who experience bladder leakage or difficulty controlling urination, as defined by the International Continence Society
  • People with an EDSS score (a scale used to measure MS-related disability) below 6.5 (confirm with trial site)
  • People with MS who are able to communicate without significant difficulty

Who may not be able to join:

  • People who have not agreed to take part in the trial
  • People whose MS medications have been changed in the last 6 months
  • People who are currently pregnant
  • People who have given birth vaginally or by caesarean section within the last 6 months
  • People who have a condition where one or more pelvic organs have dropped out of their normal position
  • People who currently have a urinary tract infection (a bladder or urinary system infection)
  • People who have had an MS relapse or attack within the past month

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Zeynep Yıldız Kızkın, Artvin Coruh University

Phone: 5346945085

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Artvin Coruh University
Registry
ClinicalTrials.gov
Start date
9 March 2026
Est. completion
30 September 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Expanded disability status scale (EDSS); Neurogenic Bladder Symptom Score (NBSS); International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF); Incontinence Impact Questionnaire (IIQ-7); Pelvic Floor Muscle Activity; International Physical Activity Questionnaire (IPAQ); Fatigue severity scale (FSS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov